Introduction
The onset of mitosis is thought to be caused by maturation promoting factor (MPF), a complex of the protein kinase Cdc2 with cyclin B (Murray and Hunt, 1993) . MPF shows the phenomenon of`ampli®cation': a small added amount of MPF causes activation of a much larger amount from an inactive precursor (Cyert and Kirschner, 1988; Dunphy and Newport, 1988) . Ampli®cation is apparently due to the fact that Cdc2/ cyclin B activates its own activating kinase Cdc25 (Homan et al., 1993) , giving rise to a positive feedback loop that makes the activation of MPF eectively autocatalytic. Evidently a cell can exist in a stable steady state with low MPF activity; but on displacement of the cell from this steady state, by addition of a small amount of MPF, the autocatalytic eect of MPF causes the cell to shift toward a dierent stable state, one with high MPF activity. Ampli®cation therefore indicates the existence of two potential stable steady states, i.e. bistability.
Bistable switching is well known in chemical engineering, and a clear and fairly simple explanation is given by Gray and Scott (1990) . In biology it has been proposed as a mechanism of memory, of dierentiation, or of conversion of continuous chemical gradients into discontinuous patterns of embryonic development (Edelstein, 1971; Seelig and Denzel, 1972; Meinhart, 1982; Murray, 1989) . Biochemical switches of the simple types considered here have been described and discussed by Edelstein-Keshet (1988) and Murray (1989) . Lewis et al. (1977) have particularly stressed that other types of biochemical switch do not show true thresholds of discontinuity, and do not provide either the sharpness or the irrevocability of bistable switches. Bistable switching is typically caused by a change in a rate constant or other parameter which changes the biochemical dynamics and destabilizes the current stable state, and thereby forces the system to go to the alternate stable state. A change of steady state may alternatively be caused by addition of substrate, as in ampli®cation of MPF; but mitosis is not normally initiated by addition of MPF, and we will focus here on switching by destabilization of a steady state.
Some cell cycle events other than mitosis are controlled by cyclin-dependent kinases (Cdks) other than Cdc2, and some of these Cdks appear to be regulated by Cdk inhibitors (CKIs) (Hunter, 1993; Pines, 1994; Elledge and Harper, 1994; Peter and Herskowitz, 1994b) . Nasmyth and Hunt (1993) have suggested that Cdks`build up like water behind a CKI dam,' and that over¯ow of Cdk from the dam triggers proteolysis or inactivation of the CKI, releasing a¯ood of Cdks that irrevocably commit the cell to the next phase of the cell cycle. Several CKIs appear to be regulated by proteolysis (McKinney et al., 1993; Schwob et al., 1994; Pagano et al., 1995) , and while mechanisms for rapidly activating the proteolysis have not been generally demonstrated, Sherr (1996) cites a report that Cdk2/cyclin E accelerates turnover of p27 Kip1 . If a Cdk activates CKI proteolysis this releases more Cdk, creating positive feedback and possibly leading to complete destruction of CKI and a stable state with CKI obliterated and Cdk freed. To prevent activation, CKI must inhibit Cdk-activated CKI proteolysis enough to protect itself and stabilize a steady state with low Cdk activity. The system is then bistable and has the potential for bistable switching.
The important characteristics of a bistable biochemical switch are (1) it always commits itself to one of two stable steady states, and does not linger in any intermediate or transitional states; (2) it can be switched rapidly from one stable steady state to another, and this may require only a small, slow signal; and (3) it shows hysteresis, in that removing the signal does not undo the response, and restoring the original steady state requires a stronger opposite signal. These characteristics, in a switch controlling the onset of mitosis or other cell cycle events, can prevent an incomplete or vacillating commitment, which might well be catastrophic. This paper attempts to give a qualitative understanding of the dynamics and biochemical kinetics underlying several types of bistable switching which may be involved in controlling events of the cell cycle. The models used are based on the experimental literature but are simpli®ed in order to show the dynamical principles.
Autocatalytic activation
We use the terms Cdc2 and Cdc2P to denote the active (tyrosine 15-dephosphorylated) and inactive (tyrosine 15-phosphorylated) forms of the Cdc2/cyclin B heterodimer, respectively.
With any autocatalytic process, a key problem is how to prevent premature activation. In the generally accepted mechanism for Cdc2 activation and inactivation ( Figure 1a ) the relative strength of autocatalysis must be relatively weak at low Cdc2 concentrations, in order to stabilize the steady state with predominantly the inactive phosphorylated form Cdc2P. Binding of Cdc2 to an inhibitor (X, Figure 1b) , preventing autocatalysis, would weaken the autocatalysis preferentially at low Cdc2 concentrations because, by the laws of chemical equilibrium, binding of Cdc2 to a ®xed amount of inhibitor would be proportionately greater at lower [Cdc2] . If the binding is very strong, the inhibitor would almost completely inhibit Cdc2 up to a stoichiometric amount, but excess Cdc2 would be uninhibited.
It has been proposed (Thron, 1994 (Thron, , 1996 , that the protein Suc1 acts as the inhibitor X in this model. Suc1 binds to Cdc2 and inhibits activation (Dunphy and Newport, 1989) , and this mechanism could explain several of the puzzling eects of Suc1 (Thron, 1994) . However this role of Suc1 now seems questionable. Recent ®ndings (Patra and Dunphy, 1996; Pines, 1996) indicate that the action of Suc1 is more complicated. Moreover, the quantity of Suc1 present vastly exceeds the quantity of cyclin B (Kobayashi et al., 1991a, b; Patra and Dunphy, 1996) . The amount of Cdc2/cyclin B is therefore much too small to titrate Suc1 stoichiometrically. Moreover, if Cdc2/Suc1 binding is partially reversible, the large excess of Suc1 would inhibit all concentrations of Cdc2/cyclin B approximately equally, and there would not be much preferential inhibition of lower concentrations. However other Cdc2-binding substances have been reported (Kumagai and Dunphy, 1995; Lee and Kirschner, 1996) which may act as the inhibitor X in Figure 1b .
In this model, there is continuous metabolic turnover between the active and inactive forms, Cdc2 and Cdc2P respectively. To analyse the mechanism we consider the case where the total of Cdc2 and Cdc2P is constant. Cdc2 is assumed to bind to the inhibitor X, but Cdc2P binding to X is assumed to be relatively much less strong (Thron, 1994 (Thron, , 1996 . Unbound Cdc2 eectively (through activation of Cdc25) accelerates its own formation, i.e. the conversion of Cdc2P to Cdc2. Since the total of Cdc2P and Cdc2 is assumed to be constant, the net rate of formation of Cdc2 equals the net rate of decrease of Cdc2P. This rate is equal to the dierence between the rate of activation F and the rate of deactivation R: remaining to be activated; and of course F becomes equal to 0 when all the Cdc2P has been converted to Cdc2.
Note that F has a small positive value when [Cdc2]=0. The importance of this will appear below.
The model attributes it to the hypophosphorylated low-activity form of Cdc25 (Zheng and Ruderman, 1993; Thron, 1996) .
From Figure 2a can be extracted the essential information on how the system behaves. Where curves R and F intersect, R equals F and the spontaneous rate of change of [Cdc2] is zero, by equation (1). The intersections of R and F therefore mark concentrations of Cdc2 at which the system has no tendency to change, i.e. the system is in a steady state. These steady state concentrations are indicated by dashed lines in Figure 2a . As can be seen in Figure 2a , the double curvature of curve F, caused by the autocatalysis and the X binding, results in three intersections with R, and hence three (potential) A dierent mode of activation is produced by increasing Cdc25 activity in the model (Figure 2b, c) . This increases the rate of Cdc2 activation and causes a portion of the curve F to shift upward until it breaks contact with curve R. In Figure 2b , curve F has shifted high enough to be just tangent to curve R at a point where the low-activity and unstable steady states have merged. In Figure 2c , a further increase in Cdc25 activity has broken this contact between F and R, and the low-activity and unstable steady states no longer exist. The direction of spontaneous change is now everywhere toward the high-activity steady state and [Cdc2] is compelled to change completely to the highactivity stable steady state.
This extinction or disappearance of the low-activity steady state is the mechanism for this mode of triggering activation of Cdc2, according to this model. This is a qualitative change in the dynamics: a bistable system becomes monostable. The general mathematical term for such a qualitative change is bifurcation (Hale and Kocak, 1991) . This particular type of bifurcation, in which a pair of steady states, one stable and one unstable, appears or disappears, is a saddle-node bifurcation (the name comes from multivariable systems, where there is what is called a`saddle point' instead of an unstable steady state).
The small positive value of F at [Cdc2]=0 is important for the reliability of triggering. If F and R were both 0 when [Cdc2]=0 (i.e. if the low-activity steady state were at the origin) then increasing the rate of Cdc2 activation could destabilize this point, but could not obliterate it. Curves F and R would never break contact at this point and the low-activity steady state would always remain as an unstable steady state, where the system might remain inde®nitely unless there happened to be a trace of active Cdc2 to start the autocatalysis.
Reversing the increase in Cdc25 activity in Figure 2b and c would restore the three intersections in Figure  2a , but it would not destabilize the high-activity steady state, and would not cause the system to shift back to the low-activity steady state. In this sense the activation of Cdc2 has been irrevocable. To force a return to the low-activity steady state would require a much more marked reduction in Cdc25 activity, to the point where the maximum in curve F no longer contacts curve R (Figure 2d ). Again there is a change in the number of steady states, this time by a dierent saddle-node bifurcation; and there remains only the low-activity steady state, to which the system must return. The Cdc25 activity at which inactivation occurs is therefore lower than the Cdc25 activity required for activation. This behavior, with a dierence between the thresholds for activation and inactivation, is hysteresis. Because of hysteresis, small random¯uctuations in the rate of Cdc2 activation will never switch the system repeatedly between high-and low-activity states. Hysteresis, together with the fact that there are never any stable intermediate-activity states, ensures that commitment to the next phase of the cell cycle is complete and eectively irrevocable. (The restoration of the switch, in the course of the cell cycle, actually proceeds by an entirely dierent pathway involving cyclin degradation).
This system is also non-accommodating: a slow or subthreshold stimulus does not desensitize the autocatalytic mechanism in the way that a subthreshold current desensitizes a nerve membrane and renders it inexcitable. Because of this, the system does not require to be stimulated by a sharp pulse, but can be triggered by a slight change in the level of a slowly-changing cellular signal. In eect, it can transduce a continuous signal into a discrete event.
The high-activity state in Figure 2c has less than 75% Cdc2 activated. More complete activation is possible with dierent parameter values (Figure 3 ), but the illustration is less satisfactory because lowactivity and unstable steady states cannot be seen well without magni®cation. Other factors may favor complete activation. For example the decrease in Wee1 activity that occurs in M phase (Smythe and Newport, 1992; Tang et al., 1993; Atherton-Fessler et al., 1994) would eectively lower the right-hand portion of curve R, so that it intersects curve F at a higher [Cdc2] . The shapes of these curves for real systems are presently unknown.
Note that triggering depends on the balance of Cdc2 turnover (activation and deactivation) in relation to the eective threshold for autocatalysis, so there are several parameter changes that might bring about triggering. These would include (in addition to Cdc25 activation) reducing the rate of Cdc2 deactivation (reducing R, inhibiting Weel) and increasing the total of Cdc2 and Cdc2P (cyclin B biosynthesis). These other ways also cause saddle-node bifurcation.
The sigmoid shape of curve F in Figure 2 is due to inhibitor binding; but a sigmoid shape can also arise without an inhibitor if the autocatalysis is proportional to the second or higher power of [Cdc2], as in the models of Novak and Tyson (1993) and Obeyesekere et al. (1995) . Also, if curve F is not sigmoid, curvature in curve R may produce three intersections and bistability if R shows saturable (e.g. Michaelis-Menten) kinetics or if, as mentioned above, Wee1 activity decreases in M phase (Thron, 1996 (Thron, , 1997a , Figure 4) .
The model of Figure 1b is essentially the same mechanism previously used to drive an oscillatory cell A process of continual CKI biosynthesis allows for steady states, but to make a stable steady state with low Cdk activity there must be a non-Cdk-dependent process of CKI destruction, in addition to the Cdk-activated CKI destruction (see Figure 5) cycle model (Thron, 1994) . Oscillatory cell cycle models have received considerable attention as models for repetitive cell division (Thron, 1994; Obeyesekere et al., 1995; Tyson, 1993, 1995) , but oscillations and repetitive cell division are outside the scope of this paper.
Activation by inhibitor proteolysis
This second model assumes that Cdk is regulated by a titratable inhibitor (CKI) and is released by sudden, rapid, and complete proteolysis of CKI. As shown in Figure 4a , CKI is assumed to bind Cdk and thereby inhibit it, and free Cdk is assumed to accelerate the proteolysis of CKI whether or not the latter is bound to Cdk. As with the previous model, a key problem is how to prevent premature activation. Any trace of free Cdk will cause slight CKI proteolysis and will thereby amplify itself by positive feedback; so the model as it stands in Figure 4a has no stable steady state until all the CKI is destroyed, i.e. it does not have a stable steady state with Cdk inhibited. In order to have a steady state with low free Cdk activity, there must be a process for continually restoring CKI, as in Figure 4b . In addition, in order to provide a stable steady state with Cdk inhibited, it is necessary that part of the CKI proteolysis not be activated by Cdk. The need for this non-Cdk-dependent proteolysis is explained below in the discussion of Figure 5 .
In this second model, total [Cdk] (free plus CKIbound) is constant, and none is in an inactive form, except through binding to CKI. The net rate of formation of CKI is the dierence between the rate of formation F and the rate of destruction R:
Here [CKI] is the total concentration of CKI, whether or not bound to Cdk. Again the key to the biochemical switching dynamics is in how the rates of formation and destruction depend on the state variable, here [CKI] . The rate of CKI formation F is assumed constant (Figure 5a) (Figure 5b ). The right-hand stable steady state, which has low free Cdk concentration, is extinguished by merging with the unstable steady state in a saddlenode bifurcation, and the system must shift to the remaining stable steady state, by proteolysis of most of the CKI, with liberation of most of the Cdk. Note that triggering does not require a sharp pulse of Cdk. Like the autocatalytic model of Figure 2 , this system can be triggered by a small slow signal without showing accommodation. This system also shows hysteresis and irrevocability: to return the system in Figure 5b from the high-activity to the low-activity state would require drastic reduction of Cdk, enough to make the`hump' of curve R lie entirely below curve F.
As can be understood from Figure 5 , proteolysis and Cdk release could also be triggered by an increase in the rate constants for Cdk-activated or non-Cdkdependent proteolysis or a decrease in F, and the triggering would be by saddle-node bifurcation.
Biphasic autoregulation
The cell cycle-regulatory transcription factor E2F-1 can apparently activate its own promoter (Johnson et al., 1994; Hsiao et al., 1994; Neuman et al., 1994) . On the other hand, complexes of the retinoblastoma gene product (RB) or related proteins with E2F-1, may be active transcriptional repressors (Neuman et al., 1994; Qin et al., 1995; Johnson, 1995) . Therefore E2F-1 can apparently have a biphasic eect on its own transcription: low concentrations inhibit transcription by binding RB to the promoter, while concentrations exceeding [RB] competitively displace the RB-E2F complexes from the promoter and exert a positive (Figure 6 ). At least in some cells, RB is normally present in considerable excess over E2F-1 (WH Lee, personal communication); but RB loses its anity for E2F-1 when it becomes phosphorylated, and E2F-1 may then exceed the concentration of hypophosphorylated RB. This sytem may be bistable, as shown in the following model. E2F-1 probably acts as a heterodimer with DP-1 (LaThangue, 1994). In the model,`E2F' denotes the active transcription factor, and it is assumed that translation and heterodimerization closely follow transcription, so that in eect E2F directly regulates its own rate of formation.`RB' denotes just the active, hypophosphorylated form of the retinoblastoma protein. There is metabolic turnover of E2F (Hofmann et al., 1996; Hateboer et al., 1996) , and the net rate of formation of E2F is the dierence between the rate of formation F and the rate of destruction R:
Here [E2F] is the total concentration of E2F, whether or not bound to RB (the amounts bound to promoter are assumed to be negligible). It is known that binding to RB inhibits the destruction of E2F (Hofmann et al., 1996; Hateboer et al., 1996) , but for simplicity the rate of E2F destruction R is here assumed proportional to the total [E2F]. The eect of RB inhibition will be discussed below. The rate of formation F (Figure 7a ) is slow at [E2F]=0, and decreases with increasing E2F because of binding of RB-E2F complexes to the promoter. When the concentration of E2F exceeds that of RB, F begins to increase because of displacement of RB-E2F by E2F, with activation of the promoter. The equation for F assumes that the promoter exists in three forms (unoccupied, occupied by two RB-E2F complexes, and occupied by two E2Fs), and that the proportions of these forms depend on the free concentrations of E2F and RB-E2F, raised to the second power, according to the usual dissociation equilibrium laws. A decrease in [RB], due for example to inactivation of RB by phosphorylation, can then obliterate the low-activity stable state by a saddle-node bifurcation (Figure 7b) , and cause an all-or-none shift to the high-activity stable state. As with the two previous models, this system does not show accommodation, but does show hysteresis and irrevocability. As noted above, binding of E2F to RB inhibits the destruction of E2F. This would decrease the slope of R where [E2F] 5 [RB] . This model can be modi®ed to include substantial RB inhibition, as long as the inhibition is not complete. If E2F removal is inhibited completely then there is no steady state unless E2F production is stopped by some other switching mechanism.
The curves in Figure 7 are somewhat similar to those in Figure 2 , but in Figure 7 curve F passes through minimum, rather than just rising sigmoidally as in Figure 2 . This is because of the biphasic autoregulation. Also the possible depletion of substrate for E2F biosynthesis has been ignored in the model of Figure 7 , so curve F does not decrease at higher E2F concentrations, in contrast to Figure 2 .
More complicated models
In the model of Figure 1 the total of Cdc2 and Cdc2P is assumed constant. In life this total changes as a result of cyclin biosynthesis. This requires a second dierential equation and a somewhat dierent graphical mode of analysis, namely`phase-plane analysis' (Edelstein-Keshet, 1988; Novak and Tyson, 1995; Tyson et al., 1995 Tyson et al., , 1996 . However these more complicated models switch in much the same way as the simpler models discussed here, by coalescence of a Figure 6 Proposed model of biphasic autoregulation. The E2F-1 promoter has two sets of overlapping E2F-binding sites (Johnson et al., 1994; Hsiao et al., 1994; Neuman et al., 1994) . E2F here indicates a transcription factor containing the gene product, e.g. a heterodimeric complex with DP-1. The E2F-1 gene is transcribed to some degree when the E2F sites on the promoter are unoccupied. In the presence of retinoblastoma factor RB, E2F binds RB to the promoter, inhibiting transcription. Excess E2F competitively displaces the E2F-RB complexes from the promoter and strongly activates transcription. The resulting further increase in E2F creates a positive feedback loop . See text for further explanation stable steady state with an unstable steady state (actually a saddle point), with resulting disappearance of the stable steady state; and they show hysteresis and not accommodation.
Discussion
These models are presented as illustrations of a dynamical principle, and not as established mechanisms. A number of assumptions and inferences have been made which have not been demonstrated experimentally. It has not been established whether a titratable inhibitor plays the role proposed here in MPF activation, or whether there is steady-state turnover of CKIs, or whether transcription of E2F-1 operates as a bistable switch. The application of any of these models to real data would undoubtedly require some re-evaluation, reinterpretation, and modi®cation of the model, and would probably also require some additional experiments. However, the object here has not been quantitative simulation of real systems, but rather insight into qualitative system behavior, principally the disappearance of a stable steady state by saddle-node bifurcation. The analysis in terms of formation and removal rate curves can be done for any system whose formation and removal rate curves are known or can be estimated.
If bistable switching is to occur, the system must have an unstable steady state, because the saddle-node bifurcation is produced by the merger of the lowactivity stable steady state with an unstable steady state, with the extinction of both. In order to have an unstable steady state the biochemical kinetics must be somewhat unusual. As can be seen in the ®gures, an unstable steady state is one where curve F crosses curve R from below upwards, as substrate concentration increases. This means that either F must increase with increasing concentration of the substance formed by F (eective autocatalysis, as in Figures 2, 3 and 7) , or R must decrease with increasing concentration of the substance removed by R (eective substrate inhibition, as in Figure 5 ). In short, the substrate must tend to increase its own net rate of production, i.e. it must bè self-activating' (Higgins, 1967) , or positively autoregulated. The term`autoregulation' is often used as if it were synonymous with negative autoregulation, because of the preoccupation with homeostasis in biology. However these reactions are not homeostatic. Their function is to produce change; and abrupt, complete, irrevocable change requires to be eected by positive feedback.
In each of these examples there is a titratable inhibitor. The role of the inhibitor is not merely to slow a rate process quantitatively, but more importantly to alter the concentration-dependence of the rate process in a way that aects the dynamics, e.g. to put à kink' in curve F or R that allows multiple intersections between F and R. The end-point of titration of a titratable inhibitor forms a more or less sharp threshold for the enhancement of positive feedback. This threshold eect is a distinctive property of a titratable or stoichiometric inhibitor, and is not produced by competitive or non-competitive inhibitors. It has already been recognized (Kato et al., 1994; Hall et al., 1995) INK4a , which are essentially competitive (Hall et al., 1995) , would not by themselves create a threshold, though by displacing p27
Kip1 from Cdk4 and Cdk6 (ReynisdoÂ ttir et al., 1995) they presumably alter the threshold created by p27 Kip1 for Cdk2/cyclin E.
Though the titration threshold is important in these examples, there are other biochemical mechanisms, without titratable inhibitors, for which the F and R curves may make the three intersections required for bistable switching, as already noted, and as shown elsewhere (Thron, 1996; 1997a) .
The stabilization of the low-activity steady state is presumably not delay for its own sake, but is important for cellular function. In the case of MPF, it may be important to prevent activation during the period of cyclin B accumulation, and thereby allow accumulation of enough pre-MPF to produce a sudden high level of MPF when activated (Thron, 1994) . The CKIs may likewise function to allow the accumulation of a reservoir of Cdk for sudden release (Nasmyth and Hunt, 1993) . Since too small a rise in MPF or Cdk might fail to initiate the next phase of the cell cycle, these inhibitors may be necessary for progress through the cell cycle, though in a sense they inhibit progress through the cell cycle.
With a stable low-activity state, and a saddle-node bifurcation, these models are potential`checkpoints' (Hartwell and Weinert, 1989; Elledge, 1996) where progress through the cell cycle can be held up inde®nitely until some required condition is met. As noted above, the models of Figures 2 and 5 can be triggered in any of several ways, which might be controlled by speci®c signals of cell size or completeness of DNA replication or repair. Novak and Tyson (1995) , in their model of the S. pombe cell cycle, have modeled checkpoints as`stable steady state[s] inserted into and removed from the cell cycle by saddle-node bifurcations' (JJ Tyson, personal communication) . A number of other theoretical checkpoint models have been suggested (Tyson et al., , 1996 Thron, 1997b) . What is proposed here is that checkpoint arrest is a steady state, with continual turnover of an eectively`self-activating' substance. Turnover is necessary because the unbalancing of the turnover is what terminates the arrest. A titratable inhibitor may be the most obvious mechanism of checkpoint arrest, but there are other possible mechanisms of bistability, as noted above. Ultimately checkpoint arrest depends on whether the continuing turnover process maintains the self-activating substance below the critical level for triggering. On this view, turnover reactions are crucial for checkpoint control. Not all of these turnover reactions have been well studied, and some, for example those proposed for the inhibitor proteolysis model (Figure 4b) , are essentially conjectural.
Experimental evidence for bistability would include (1) ampli®cation, as with MPF, (2) a sudden, discontinuous change of stable state during a gradual change of a rate constant or other parameter (saddlenode bifurcation), and (3) hysteresis or lack of reversibility. Any system showing a rapid change after a period of apparent stability could in principle be tested for ampli®cation as was done by Cyert and Kirschner (1988), by adding a small amount of the product of a previously activated sample; and if this precipitates or accelerates the activation it would be evidence of autocatalysis or positive feedback. Novak and Tyson (1993; Tyson et al., 1996) have suggested that diering thresholds for activation and inactivation (hysteresis) might be experimentally demonstrable in the activation of p34 cdc2 by cyclin (Solomon et al., 1990) ; and the suggestion still seems valid in principle, although more recent ®ndings (Lee and Kirschner, 1996) would have to be taken into account. Titration curves of Cdks with p21
Cip1 or p27 Kip1 are sometimes quite steep (Xiong et al., 1993; Polyak et al., 1994; Jackson et al., 1995; Fotedar et al., 1996) , and this suggests the possibility of positive feedback, if not bistability. Some considerations in evaluating experimental observations are (1) on destabilization of a steady state, the change to a new steady state may not occur instantaneously, but may rather be gradual, though inevitable; (2) in multicellular systems, abrupt changes in individual cells tend to be disguised by cellular asynchrony; and (3) in cell extracts the molecular architecture may be disrupted in a way that aects the biochemical kinetics.
The picture of the cell cycle is becoming increasingly complicated (Sherr, 1996) , and there are now a number of proposed positive-feedback loops, in addition to those already mentioned, that might produce bistable switching: (a) E2F-1 activates the cyclin E promoter (Ohtani et al., 1995; Geng et al., 1996) and Cdk2/cyclin E probably phosphorylates RB (Weinberg, 1995) , liberating E2F-1; (b) Cdk2/cyclin E activates Cdc25A, which may also activate cyclin E/Cdk2 (Homann et al., 1995) ; (c) expression of cyclin D1 leads to an apparently E2F-1-dependent activation of the MYC promoter (Oswald et al., 1994) and Myc induces cyclin D1 expression (Daksis et al., 1994) ; (d) Mos activates MAP kinase, and MAP kinase induces synthesis of Mos (Roy et al., 1996) ; and (e) CLN2 in Saccharomyces cerevisiae activates its own transcription (Nasmyth, 1993; Stuart and Wittenberg, 1995) , and Far1 is apparently a titratable inhibitor (Peter and Herskowitz, 1994a) . Myc also activates cyclin E/Cdk2 (Steiner et al., 1995) and activates transcription of Cdc25A (Galaktionov et al., 1996) . Finally, proteolysis of Cdk activators, as well as inhibitors, plays an important part in cell cycle progression (King et al., 1996) , and this may well be switched by a bistable mechanism.
Whether these positive-feedback loops actually produce bistable switching is a question that can only be answered experimentally. It is suggested here that this question can be approached by analysis of formation and removal rates, with identi®cation of the nature of the positive feedback, the mechanism preventing premature activation, the turnover reactions stabilizing the low-activity steady state, and the mechanism of destabilization.
Note added in proof It has been reported that Cdk2/cyclin E causes phosphorylation of p27
Kip1 which results in elimination of p27
Kip1 from the cell (Shea RJ, Groudine M, Gordon M, Roberts JM and Clurman BE, Genes Devel., in press). This system may therefore be similar to the inhibitor proteolysis model of Figure 4 .
